Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of V0116 Nicotine Patch
NCT02089308Phase 1Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Mar 2014
- Primary completion
- May 2014
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of nicotine patch in nicotine dependence (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Concentration and 1 more. Started Mar 2014; status: completed.
02
Drugs
nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02089308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02089308.